Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/25/2001WO2001079297A1 Agent against periodontal disease
10/25/2001WO2001079296A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family
10/25/2001WO2001079295A2 20716, a g-protein coupled receptor and uses therefor
10/25/2001WO2001079294A2 Human proteins, polynucleotides encoding them and methods of using the same
10/25/2001WO2001079293A2 Human cadherin molecules and uses therefor
10/25/2001WO2001079292A2 Novel g protein-coupled receptors
10/25/2001WO2001079291A2 Secreted proteins
10/25/2001WO2001079290A2 Glp-2 receptor gene promoter and uses thereof
10/25/2001WO2001079289A2 Human interferon, zinf2
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001WO2001079285A1 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001WO2001079280A1 A novel polypeptide - human ccr4 protein 16 and the polynucleotide encoding said polypeptide
10/25/2001WO2001079279A1 A novel polypeptide-homo tnf receptor-associated factors 16 and polynucleotide encoding said polypeptide
10/25/2001WO2001079278A1 Lactobacillus johnsonii bacteriocin, active against helicobacter pylori
10/25/2001WO2001079277A2 Immunogenic pili presenting foreign peptides, their production and use
10/25/2001WO2001079276A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/25/2001WO2001079275A2 STAPHYLOCOCCAL GENE, vgaC, CONFERRING RESISTANCE TO STREPTOGRAMIN A AND RELATED COMPOUNDS
10/25/2001WO2001079274A2 Tuberculosis antigens and methods of use thereof
10/25/2001WO2001079273A2 Viruses comprising mutated ion channel protein
10/25/2001WO2001079272A2 Sitosterolemia susceptibility gene (ssg): compositions and methods of use
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079270A2 Migraine and vasodilation treatment
10/25/2001WO2001079269A2 Lipid binding protein 4
10/25/2001WO2001079266A1 Antibody against human kgfr
10/25/2001WO2001079260A1 Haemostatically active preparation containing vwf and method for the production thereof
10/25/2001WO2001079259A1 Javelinization of protein antigens to heat shock proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079257A2 Multidrug resistance (mdr) efflux pump polypeptides
10/25/2001WO2001079254A1 Novel nucleic acids and polypeptides
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079252A1 ASSOCIATION OF β2-ADRENERGIC RECEPTOR HAPLOTYPES WITH DRUG RESPONSE
10/25/2001WO2001079250A1 Enhanced protein thermostability and temperature resistance
10/25/2001WO2001079225A2 Haplotypes of the csf1r gene
10/25/2001WO2001079222A2 Haplotypes of the mc4r gene
10/25/2001WO2001079216A2 Polyamide nucleic acid derivatives, agents and methods for producing them
10/25/2001WO2001079144A2 Fyn kinase as a target for modulation of integrin mediated signal transduction
10/25/2001WO2001079131A1 Cementitious composition containing glass powder as a pozzolan
10/25/2001WO2001078894A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/25/2001WO2001078877A1 Electrophoresis separation and treatment of samples
10/25/2001WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001WO2001078790A2 GENE THERAPHY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING A β2ADRENERGIC RECEPTOR GENE
10/25/2001WO2001078776A1 Herpes virus complementing cell line
10/25/2001WO2001078775A2 A method for making an hiv vaccine
10/25/2001WO2001078774A2 Recombinant intracellular pathogen vaccines and methods for use
10/25/2001WO2001078772A1 Heat shock protein-based antiviral vaccines
10/25/2001WO2001078770A1 Inhibition of transmission of tick-borne infections
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078767A2 Pharmaceutical preparations comprising modified peptides
10/25/2001WO2001078756A2 Agent for postoperative use after the removal of bone tumours
10/25/2001WO2001078755A2 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same
10/25/2001WO2001078655A2 Methods and compositions for heat shock protein mediated immunotherapy of melanoma
10/25/2001WO2001078503A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001WO2001049317A9 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/25/2001WO2001044512A8 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression
10/25/2001WO2001040512A3 Resistance gene
10/25/2001WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001WO2001038584A3 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
10/25/2001WO2001036636A3 Human notch ligand proteins and polynucleotides encoding the same
10/25/2001WO2001024765A3 Antigenic modification of polypeptides
10/25/2001WO2001023597A3 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
10/25/2001WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits
10/25/2001WO2001023421A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
10/25/2001WO2001022092A3 Method to identify compounds which modulate fra-1 expression fils
10/25/2001WO2001021794A3 Smad associating polypeptides
10/25/2001WO2001021762A3 Method of decreasing cholesterol uptake
10/25/2001WO2001021643A3 Parathyroid hormone analogues for the treatment of osteoporosis
10/25/2001WO2001018044A3 Use of semaphorin for modulation of cellular efflux
10/25/2001WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof
10/25/2001WO2001012126A3 Cardiomyocyte regeneration
10/25/2001WO2001005986A3 Mites-like element and transcriptional activation element
10/25/2001WO2001005957A3 Grapevine leafroll-associated virus proteins
10/25/2001WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
10/25/2001WO2000068249A3 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor
10/25/2001WO2000065090A3 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders
10/25/2001WO2000054573A9 Geminivirus resistant transgenic plants
10/25/2001WO2000043492A9 Method of site specific labeling of proteins and uses therefor
10/25/2001WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001US20010034886 Rad2/FEN-1 orthologues and uses thereof
10/25/2001US20010034885 Non-human animal deficient in function of pituitary adenylate cyclase-activating polypeptide gene
10/25/2001US20010034884 Abeta-peptide screening assay
10/25/2001US20010034438 24 contiguous bases of nucleotide sequence in the G-protein coupled receptor polynucleotide sequence
10/25/2001US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001US20010034433 Inhibition of growth of somatomedin dependent cancers, the effect of somatomedin-c in acromegaly, the growth of retinal blood vessels and fibrous tissues in diabetic retinopathy, growth of tall children, etc.; antiscarring agents
10/25/2001US20010034334 Genetic engineered polypeptide
10/25/2001US20010034331 Isolated polypeptide
10/25/2001US20010034324 Immunostimulation
10/25/2001US20010034322 Taxol-like protein (TALP) and process for preparing the same
10/25/2001US20010034053 Pure antithrombin-III, the antithrombin isoforms AT-III alpha and AT-III beta, and/or histidine-rich glycoprotein by usng a cation exchange gel wherein the cation exchanger group is attached to the gel matrix by a linear polymer chain
10/25/2001US20010034052 A breast tumor polypeptide(s), immunogenic portions thereof, polynucleotides that encode such peptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides; vaccines
10/25/2001US20010034050 Fusion peptides isolatable by phase transition
10/25/2001US20010034045 Inducing an elevated unfolded protein response by using an isolated heterologous nucleic acid endocing a HAC1 protein, a PTC2 protein or an 1re1 protein
10/25/2001US20010034044 Genomic sequences for protein production and delivery
10/25/2001US20010034042 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
10/25/2001US20010034035 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier
10/25/2001US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
1 ... 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 ... 2916